Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

25 projects found matching your search criteria :

  1. Halogen bonding - the role and significance in interactions of ligands with class A GPCRs

    Call: SONATA 8 , Panel: NZ7

    Principal investigator: dr Rafał Kurczab

    Instytut Farmakologii PAN

  2. Unusual 5-HT6 receptor ligands

    Call: OPUS 7 , Panel: NZ7

    Principal investigator: prof. Andrzej Bojarski

    Instytut Farmakologii PAN

  3. Aromatase and estrogen receptors gene expression in human testicular tissues with normal and impaired spermatogensis

    Call: OPUS 7 , Panel: NZ4

    Principal investigator: prof. Krzysztof Kula

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  4. Synthesis and biological evaluation of pyrrolidine-2,5-dione derivatives as potential antidepressant agents.

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: dr Andrzej Chodkowski

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  5. Development of a tool for automatic evaluation of complexes of ligands with serotonin receptors based on the application...

    Call: PRELUDIUM 5 , Panel: NZ2

    Principal investigator: Sabina Podlewska

    Instytut Farmakologii PAN

  6. Obtaining of new quinoline derivatives with potential activity for serotonin receptors and inhibition of serotonin reupt...

    Call: PRELUDIUM 5 , Panel: NZ7

    Principal investigator: Przemysław Taciak

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  7. Cooperative involvement of serotonergic signaling and extracellular matrix in synaptic plasticity underlying the pathoge...

    Call: HARMONIA 3 , Panel: NZ3

    Principal investigator: dr hab. Jakub Włodarczyk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  8. The group III metabotropic glutamate receptors as a target for future antypsychotic drugs

    Call: MAESTRO 3 , Panel: NZ7

    Principal investigator: prof. Andrzej Pilc

    Instytut Farmakologii PAN

  9. Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the conte...

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: dr Magdalena Kolasa

    Instytut Farmakologii PAN

  10. In the search for active compounds among ligands of serotonin, particularly 5-HT7, and dopamine receptors, with potentia...

    Call: OPUS 1 , Panel: NZ4

    Principal investigator: prof. Anna Wesołowska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  11. Probing the selectivity of zinc allosteric modulation in various serotonin receptor subtypes

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: Grzegorz Satała

    Instytut Farmakologii PAN

  12. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

  13. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Kinga Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

  14. Role of peroxisome proliferator-activated receptors (PPARs) and free fatty acid receptors (FFARs) in androgen-dependent ...

    Call: PRELUDIUM 21 , Panel: NZ3

    Principal investigator: Joanna Cyran-Gryboś

    Uniwersytet Jagielloński, Wydział Biologii

  15. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Marcin Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

  16. Expression and function of Regulator of G Protein Signaling (RGS) proteins in physiological and pathophysiological condi...

    Call: SONATA 16 , Panel: NZ7

    Principal investigator: dr hab. Maciej Sałaga

    Uniwersytet Medyczny w Łodzi

  17. New 5-HT6 receptor ligands from the group of sulfonamide derivatives of cyclic arylguanidines in the treatment of gliobl...

    Call: PRELUDIUM 19 , Panel: NZ7

    Principal investigator: Przemysław Zaręba

    Politechnika Krakowska im. Tadeusza Kościuszki, Wydział Inżynierii i Technologii Chemicznej

  18. Thymol-derived 1,3,5-triazines, the non-indole and non-sulfone 5-HT6 receptor ligands, as a starter in search for an inn...

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Jadwiga Handzlik

    Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  19. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni...

    Call: SONATA 14 , Panel: NZ7

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  20. Development of a group of non-basic ligands of serotonin receptor 5-HT7, derivatives of 2-(6-oxo-3-phenyl-1,6-dihydropyr...

    Call: SONATINA 2 , Panel: NZ7

    Principal investigator: dr Sabina Podlewska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  21. Anilide derivatives of long-chain cyclic amines as multifunctional serotonin receptors ligands and phosphodiesterase 7 i...

    Call: PRELUDIUM 13 , Panel: NZ7

    Principal investigator: dr Agnieszka Jankowska

    Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  22. The determination of ADME-Tox in vitro for potential CNS-drug candidates acting as potent and selective ligands of serot...

    Call: PRELUDIUM 11 , Panel: NZ7

    Principal investigator: Annamaria Lubelska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  23. Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

    Call: HARMONIA 7 , Panel: NZ7

    Principal investigator: Sabina Podlewska

    Instytut Farmakologii PAN

  24. Changes in neurogenesis during withdrawal from nicotine self-administration in rats - role of serotonin (5-HT)2C recepto...

    Call: OPUS 9 , Panel: NZ4

    Principal investigator: dr Magdalena Zaniewska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. Traizine 5-HT6 receptor ligands - new perspective for therapy of current civilization CNS-diseases

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Jadwiga Handzlik

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny